STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC. – Trademark Portfolio

Entity Type: 03

STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. The owner is based in San Mateo, CA.

P.O. Box 6637

San Mateo, CA 94403

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC. have?

STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC. has 2 U.S. trademarks filed with the USPTO.

What trademark classes does STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC. file in?

STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What is STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC.'s trademark registration success rate?

STEPPING STONES CENTER FOR AUTISTIC SPECTRUM DISORDERS, INC. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.